Supriya Announce Agreement To Market Plasma Nutrition’s IoProtein In India

Mumbai : API company Supriya Lifescience has announced a recent collaboration with Plasma Nutrition, a US-based nutrition company located in Delaware.

The strategic partnership involves an exclusive technology licensing agreement, granting Supriya Lifescience the sole rights for manufacturing and marketing Ingredient Optimised Protein (ioProtein) in India.

The primary purpose of this collaboration is to bring the optimised protein into the Indian market. ioProtein is a patented process (patent pending in the US) This revolutionary protein powder is designed for use as protein supplements and boasts a significant advantage, and it is highly bioavailable. This means that higher amounts of proteins are absorbed quickly by the body, providing consumers with a more effective and efficient protein supplement.

During the term of the agreement, Supriya Lifescience will lead the manufacturing and marketing of ioProtein in India. This marks the introduction of a new category of protein powders in the Indian market, and it is relatively healthier compared to other popular protein powders available through various gyms, general stores, and digital marketing channels.

“We are thrilled to be the exclusive partner of Plasma Nutrition, in introducing the innovative ioProtein to the Indian market,” said Dr Saloni Wagh, Executive Director at Supriya Lifescience.

“This strategic partnership represents our commitment to providing high-nutrition solutions to consumers in India. With ioProtein’s high bioavailability and its unmatched advantage, we are confident that the ‘IO’ technology will revolutionise the nutrition industry and become the preferred choice for health-conscious individuals,” Dr Wagh added.

“We are excited to collaborate with Supriya Lifescience and bring our patented ioProtein technology to India,” said Chris Flynn-Rozanski, co-founder & CEO at Plasma Nutrition.

“India’s rapidly growing demand for protein supplements present an excellent opportunity for us to introduce this highly bioavailable protein powder, which has already been well-received in other markets. We believe this partnership will create a new standard for protein supplementation in India,” Flynn-Rozanski said.

Related Posts

  • Pharma
  • June 21, 2025
  • 67 views
Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC

New Delhi: In a regulatory relief to the company, the Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organisation (CDSCO) has recommended…

  • Pharma
  • June 21, 2025
  • 84 views
In Punjab, 2 arrested with 6 kg heroin, pistol in cross-border drug bust

Punjab Police busted a cross-border drug smuggling racket with the arrest of two persons who were allegedly in touch with a Pakistan-based smuggler, a top police officer said on Saturday.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC

Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC

In Punjab, 2 arrested with 6 kg heroin, pistol in cross-border drug bust

In Punjab, 2 arrested with 6 kg heroin, pistol in cross-border drug bust

CDSCO flags 186 drugs that fail to meet quality standards

CDSCO flags 186 drugs that fail to meet quality standards

Pristyn’s Hat Trick, transcends North pushing envelop to South of Vindhyas

Pristyn’s Hat Trick, transcends North pushing envelop to South of Vindhyas